Author/Authors :
sumida, yoshio aichi medical university - division of hepatology and pancreatology, department of internal medicine, Karimata, Japan , okanoue, takeshi saiseikai suita hospital - hepatology center, Osaka, Japan , nakajima, atsushi yokohama city university - department of gastroenterology and hepatology, Kanagawa, Japan
Abstract :
Letter to the Editor: We read with great interest the article by Wong and colleagues (1). Hepatic fibrosis is the most important determinant of mortality in patients with NAFLD (2). Although noninvasive tests or imaging modalities such as FibroScan and MR elastography have been developed for evaluation of hepatic fibrosis (3), liver biopsy is now the gold standard.
